Form 4: Colgate-Palmolive Director Bilbrey Exercises Options and Sells Shares

Director John P. Bilbrey exercised stock options and sold shares of Colgate-Palmolive common stock on May 1, 2024.

Summary

• On May 1, 2024, John P. Bilbrey, a director of Colgate-Palmolive, exercised stock options for 6,329 shares at a price of $62.04.
• Simultaneously, Bilbrey sold 6,329 shares at $91.5936 per share.
• Following these transactions, Bilbrey directly owns 30,236 shares of common stock and indirectly owns 4,719 shares through a trust.
• He also holds options to purchase 0.0000 shares.
• The stock options were granted under the issuer's incentive compensation plan and became exercisable in one-third increments beginning on May 14, 2019.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director, indicating a neutral sentiment.

Industry Context

Executive stock option exercises and sales are a common practice in publicly traded companies as part of their compensation packages. These transactions are closely monitored by investors for insights into management's perspective on the company's future performance.

Comparison to Industry Standards

• Executive compensation packages, including stock options, are standard practice among large, publicly traded companies like Colgate-Palmolive.
• Companies such as Procter & Gamble (P&G) and Unilever also utilize stock options as part of their executive compensation plans.
• The exercise and sale of shares by executives are typically governed by company policies and insider trading regulations, ensuring transparency and fairness.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the change in ownership, but it is unlikely to be significant.
• The exercise of stock options reflects the director's participation in the company's incentive compensation plan.

Key Dates